Cargando…
Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906546/ https://www.ncbi.nlm.nih.gov/pubmed/31537696 http://dx.doi.org/10.1183/13993003.01188-2019 |
| _version_ | 1783478366849990656 |
|---|---|
| author | Kreuter, Michael Lederer, David J. Cottin, Vincent Kahn, Nicolas Ley, Brett Vancheri, Carlo Weycker, Derek Atwood, Mark Kirchgaessler, Klaus-Uwe Ryerson, Christopher J. |
| author_facet | Kreuter, Michael Lederer, David J. Cottin, Vincent Kahn, Nicolas Ley, Brett Vancheri, Carlo Weycker, Derek Atwood, Mark Kirchgaessler, Klaus-Uwe Ryerson, Christopher J. |
| author_sort | Kreuter, Michael |
| collection | PubMed |
| description | This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR |
| format | Online Article Text |
| id | pubmed-6906546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69065462019-12-16 Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Kreuter, Michael Lederer, David J. Cottin, Vincent Kahn, Nicolas Ley, Brett Vancheri, Carlo Weycker, Derek Atwood, Mark Kirchgaessler, Klaus-Uwe Ryerson, Christopher J. Eur Respir J Agora This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR European Respiratory Society 2019-12-12 /pmc/articles/PMC6906546/ /pubmed/31537696 http://dx.doi.org/10.1183/13993003.01188-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Agora Kreuter, Michael Lederer, David J. Cottin, Vincent Kahn, Nicolas Ley, Brett Vancheri, Carlo Weycker, Derek Atwood, Mark Kirchgaessler, Klaus-Uwe Ryerson, Christopher J. Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title | Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title_full | Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title_fullStr | Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title_full_unstemmed | Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title_short | Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| title_sort | concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis |
| topic | Agora |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906546/ https://www.ncbi.nlm.nih.gov/pubmed/31537696 http://dx.doi.org/10.1183/13993003.01188-2019 |
| work_keys_str_mv | AT kreutermichael concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT ledererdavidj concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT cottinvincent concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT kahnnicolas concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT leybrett concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT vanchericarlo concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT weyckerderek concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT atwoodmark concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT kirchgaesslerklausuwe concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis AT ryersonchristopherj concomitantmedicationsandclinicaloutcomesinidiopathicpulmonaryfibrosis |